A medical revolution is taking place in oncology one molecule at a time. HER2-targeted therapies once considered a niche solution for a small subset of cancer patients are now reshaping how doctors treat some of the most aggressive tumors. These therapies are powered by HER2 antibodies—highly specialized biological agents designed to find and fight cancer cells with pinpoint precision...